Vitabrid Japan Inc.

Vitabrid Japan Inc.

542A.T
Vitabrid Japan Inc.JP flagTokyo Stock Exchange
1,106.00
JPY
-10.00
- -
5.99BMarket Cap
Vitabrid Japan Inc.
542A.T
(Tokyo Stock Exchange)

Recent

price

1,106.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
2026
FRC
3,121.27
3,346.32
2,731.53
Revenue per Share
190.53
121.88
123.12
Basic EPS, GAAP
-227.03
200.17
307.37
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
270.46
361.72
499.07
Book Value per Share
260.34
345.02
490.1
Tangible Book Value per Share
4
4
6
Basic Weighted Avg Shares
11,773
12,622
15,297
Sales/Revenue/Turnover
8.48
5.55
6.68
Operating Margin (%)
31
35
35
Depreciation Expense
719
460
689
Net Income, GAAP
26.45
32.15
28.79
Effective Tax Rate (%)
6.1
3.64
4.51
Profit Margin (%)
1,558
1,996
2,549
Working Capital
362
310
104
LT Debt
1,515
2,026
2,795
Total Equity
- -
12.13
16.78
Return on Invested Capital (%)
- -
12.42
16.85
Return on Capital (%)
- -
25.97
28.61
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
37.97%
Free Cash Flow
- -
- -
127.97%
Net Income, GAAP
- -
- -
49.97%
Sales/Revenue/Turnover
- -
- -
21.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
11,773
2025
- -
- -
- -
- -
12,622
2026
4,274
3,702
- -
- -
15,297

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
190.53
2025
- -
- -
- -
- -
121.88
2026
- -
- -
- -
- -
123.12

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Vitabrid Japan Inc. engages in the development, manufacture, and sale of dermatology and cosmetic products based on Vitabrid technology, focusing on active ingredient delivery for skin care. The company operates as a research-driven cosmetics and life sciences entity, commercializing skincare formulations, serums, lotions, and related consumer and professional skin treatment products through brand names and private-label offerings. Main products and services: dermatology-grade skincare products and cosmeceuticals; delivery-enhanced anti-aging, brightening, and hydration formulations; consumer retail skincare lines; professional and clinical use products distributed through dermatology clinics and medical channels; research and development services in skin biology, biomaterial delivery systems, and formulation optimization; contract manufacturing and private-label production for third parties; regulatory and quality assurance support for cosmetic and dermal products. Latest major company changes: enters into strategic partnerships with biotech and ingredient suppliers to advance Vitabrid’s delivery platforms; completes funding rounds expanding capital for R&D and manufacturing scale-up; launches new product families and enhancements leveraging Vitabrid technology; expands into regional markets and strengthens distribution networks; undergoes branding and organizational refinements to align with global expansion. Additional context: industry segment includes cosmetics, dermatology, and life sciences; targets consumers seeking advanced skincare solutions and clinics seeking efficacious dermatology products; geographic operations span Japan and international markets through distributors and e-commerce, with potential presence in Asia-Pacific, North America, and Europe; founded year and headquarters located in Tokyo, Japan; may include subsidiaries and partnerships within the Vitabrid corporate family and related entities.